UK Archives - Carey Danis & Lowe

UK Doctors Warn Patients of Yasmin & Yaz Side Effects

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuit_yasmin_side_effects_lawsuits_dvt_blood_clot_settlementsAn article recently published by UK news organization the Daily Mail describes the country’s increased efforts in requiring physicians to adequately warn patients of the risks of using certain kinds of oral contraceptives. The article specifically mentions the oral contraceptive drug, Yasmin, which is manufactured by Bayer, the pharmaceutical company behind Yaz.

Health officials in the UK announced their new initiative amid reports that newer types of oral contraceptives place women at two times the risk of developing blood clots.

Both Yasmin and Yaz contain a newer type of synthetic hormone, what is called a third-generation progestin. A number of these third-generation progestins have been linked to an increased risk in the development of blood clots. Drospirenone, the type of progestin present in both Yasmin and Yaz, as well as generic counterpart Ocella, is just such a progestin that has been linked through numerous studies to a higher risk of venous thromboembolism.

The personal injury and defective drug lawyers at Carey Danis & Lowe are encouraged to see health officials in the United Kingdom act on the serious threats posed by Yasmin and Yaz to patient health and safety.

Carey Danis & Lowe represents victims of Yasmin and Yaz across the United States. If you believe that you have been injured by Yasmin or Yaz, we welcome you to begin exploring your legal options and eligibility for compensation today with a Carey Danis & Lowe attorney. Our initial case evaluations are free.

Carey Danis & Lowe is available to listen to your story today. Share with us how Yasmin or Yaz has impacted your health and quality of life. Contact Carey Danis & Lowe by phone at 800.721.2519, or complete one of our confidential personal injury claim forms.

$4 Billion DePuy ASR Hip Settlement in the Works

By | Defective Medical Device litigation, Hip/Knee Replacement, Product Liability, Uncategorized

DePuy ASR Hip Replacement Lawsuit Update: Trials Scheduled to Begin this Year in Maryland, New Jersey, and OhioClaims targeted at DePuy, a unit of Johnson & Johnson, over their ASR hip implant may soon be settled following the announcement of a $4 billion agreement intended to settle approximately 7,500 DePuy ASR hip lawsuits in state and federal courts across the country. According to Bloomberg, plaintiffs have filed lawsuits against DePuy and Johnson & Johnson claiming that their ASR hip implant was defectively designed, compromised health, and required numerous revision surgeries.

It is estimated that each plaintiff will receive a compensation package of around $300,000 for each of their surgical operations, though this could change depending upon a plaintiff’s age and other factors, such as the severity of injuries incurred from the ASR hip implant.

Approximately 12,000 lawsuits are pending in state courts in California, New Jersey, and Illinois. In Toledo, Ohio, DePuy ASR hip lawsuits have been consolidated into a multidistrict litigation (MDL) called In re: DePuy Orthopedics, Inc., ASR Hip Implant Products Liability Litigation, MDL no. 2197, which is being heard in the U.S. District Court for the Northern District of Ohio.

DePuy ASR Hip Implant History

In 2005, DePuy began selling their ASR hip implant in the U.S. Five years later, in August 2010, the metal-on-metal hip implant was recalled due to its high failure rate. DePuy removed approximately 93,000 hip implants from the market in the U.S. and around the world.

To explain their reason for the recall, DePuy pointed to a UK study whose data revealed a 12 – 13 percent failure rate for the ASR XL Acetabular System and the ASR Hip Resurfacing System, a model sold outside the U.S. that was never approved by the U.S. Food and Drug Administration (FDA) due reports that it released excessive amounts of metal particles.

Though the UK study reported an abnormally high failure rate, it appears that Johnson & Johnson and DePuy had gathered their own data that showed an even higher failure rate at 37 percent within 4.6 years. Additionally, the New York Times reported that two years before the DePuy ASR hip recall, a DePuy consultant notified the head of the DePuy orthopedic unit about the ASR hip implant’s defective design.

Thus, there were a number of warning signs alerting DePuy and Johnson & Johnson as to the flawed nature of their ASR metal-on-metal hip implant.

Future of DePuy ASR Hip Lawsuits

Though the current settlement amount is estimated to be around $4 billion, sources say this number could increase as patients continue to develop problems with the defective medical device in the near future, and require revision and replacement surgeries.

As it stands, DePuy’s agreement appears to contain nothing that could potentially hinder patients from trying to obtain a compensation package from DePuy and Johnson & Johnson to cover medical expenses.

This means that, at the current moment, the settlement has no limit.

How Carey Danis & Lowe Can Help You

The defective medical device lawyers at Carey Danis & Lowe are encouraged by the news of the $4 billion DePuy ASR hip settlement. As a law firm that represents victims of the DePuy ASR hip implant, Carey Danis & Lowe hopes that case resolution following this settlement is swift and efficient, as so many people have claimed pain, suffering, and injury from this defective medical device.

If you believe that you have incurred injuries from the DePuy ASR hip implant, contact a defective medical device lawyer at Carey Danis & Lowe to discuss your legal options and for assistance with filing a DePuy ASR hip lawsuit. When contacting our St. Louis based law firm, you can also speak with one of our on-staff nurses about metal-on-metal hip implant safety concerns.

Share your DePuy ASR hip implant story with Carey Danis & Lowe today by calling 800.721.2519, or by submitting a confidential personal injury claim.

Learn more about the DePuy ASR hip and personal injury litigation on the Carey Danis & Lowe blog. Stay current on the latest defective medical device news, such as the recent metal-on-metal hip implants ban in UK hospitals.

UK Prohibits Metal-on-Metal Hip Implants

By | Defective Medical Device litigation, Hip/Knee Replacement, Uncategorized

depuy_hip_replacement_asr_kransky_settlement_verdict_lawsuitFollowing a study whose data revealed an unusually high failure rate of 43 percent for certain types of metal-on-metal hip implants, the UK has prohibited the use of these types of hip implants in National Health Service (NHS) hospitals. Involving 17,000 participants, the study recorded a significant number of instances wherein metal-on-metal hip implants showed signs of serious erosion.

The Telegraph found that many metal-on-metal hip implants do not meet failure rate standards, especially the DePuy ASR Hip Replacement system. This hip implant has a documented failure rate of 13 percent over a five year period. That failure rate increases with time, as some estimates show a 43 percent rate of failure nine years after initial implantation.

Due to its defective natu, the DePuy ASR hip implant has since been removed from the market.

According to a former president of the British Orthopaedic Association, who was interviewed for the Telegraph report, if left in the body, a defective metal-on-metal hip replacement can damage surrounding tissue.

The U.S. Food and Drug Administration (FDA) has also warned about the harm metal-on-metal hip implants can cause. The FDA has noted that metal-on-metal hip implants have been known to release metal particles into the body, and as such, destroy surrounding tissue and bone. Metal particles can also enter the bloodstream, and cause neurological problems.

How can Carey Danis & Lowe Help You?

If you received an implant of the DePuy ASR Hip Replacement system, and have experienced health complications that you believe are the result of device failure and defective design, you have a case that may make you eligible to receive compensation. The defective medical device attorneys at Carey Danis & Lowe are currently investigating cases involving the DePuy ASR Hip Replacement. We invite you to contact our St. Louis based law firm for a free case evaluation, and for assistance with filing a DePuy ASR Hip lawsuit.

If you have concerns about how metal-on-metal hip implants can impact health, speak with one of our on-staff medical experts.

Share your DePuy ASR Hip story with Carey Danis & Lowe today. Call us at 800.721.2519, or complete a confidential personal injury claim.

UK Health Organizations Conduct Study on Transvaginal Mesh Safety

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

UK Health Organizations Conduct Study on Transvaginal Mesh SafetyIn the United Kingdom, the Department of Health and the Medicines and Healthcare Products Regulatory Agency (MHRA) have been collaborating on a safety review of transvaginal mesh. Their collaborative effort results from an observed need to analyze the safety of these medical devices and to provide UK surgeons, gynecologists, and urologists with the most current and pertinent information regarding transvaginal mesh and transvaginal tape.

One recommendation made by the reviewing body was to create a registry of patients who have received surgical implantation of either transvaginal mesh or transvaginal tape. The UK health officials hope to develop such a registry in order to make the data available to surgeons for review of post-surgery patient health.

In conducting its own analysis of reports and data relating to the safety of transvaginal mesh and transvaginal tape, the U.S. Food and Drug Administration discovered that severe health complications related to the surgical implantation of these vaginal medical devices are not rare. Furthermore, in its scientific literature review, the FDA made the conclusion that there was no significant benefit in using transvaginal mesh versus a non-mesh device in treating patients with pelvic organ prolapse (POP).

Also, the FDA noted that the most commonly reported transvaginal mesh health complication is vaginal mesh erosion.

Transvaginal mesh and transvaginal tape are used to treat women suffering from stress urinary incontinence (SUI) or pelvic organ prolapse (POP). Patients have reported to the MHRA in the UK and the FDA in the U.S. a number of severe health complications resulting from surgical implantation of transvaginal mesh. These serious health complications include vaginal bleeding, vaginal pain, painful intercourse, infection, scarring, transvaginal mesh erosion, and damage to surrounding tissues and organs.

Furthermore, some women must undergo revision or corrective surgeries following the initial implantation of their transvaginal mesh or transvaginal tape.

In the United States, transvaginal mesh and transvaginal tape manufacturers have pulled their defective medical devices off the market. Johnson & Johnson has removed four of its transvaginal mesh and transvaginal tape products from the market following increased reports of severe health complications related to these products. The Johnson & Johnson vaginal mesh recall included the Gynecare TVT Secur system, the Gynecare Prosima, the Gynecare Prolift and the Gynecare Prolift+M.

If you or a loved one has suffered from a transvaginal mesh or transvaginal tape implant, do not suffer in silence, and learn more about filing a defective surgical mesh claim. To file a transvaginal mesh lawsuit, contact an experienced defective medical device lawyer at Carey Danis & Lowe.